Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC versus EC adjuvant chemotherapy cardiotoxicity trial in early breast cancer
ChiCTR-IPR-14005713Phase 4Suspended
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pirarubicin, epirubicin and cyclophosphamide in breast cancer (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: Electrocardiogram changes, Echocardiogram and 1 more. Started Oct 2012; status: suspended.
02
Drugs
pirarubicinepirubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-IPR-14005713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005713.